|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||13.59 - 13.73|
|52-week range||12.45 - 18.45|
|Beta (5Y monthly)||1.15|
|PE ratio (TTM)||12.41|
|Forward dividend & yield||0.53 (3.86%)|
|Ex-dividend date||02 May 2022|
|1y target est||N/A|
The Fears Nachawati law firm is asking a federal judge to reject a proposed settlement between Bayer (OTCMKTS: BAYZF, BAYRY) and its Monsanto subsidiary and a group of consumers seeking reimbursement for their purchases of the Roundup weedkiller, saying the agreement may be the result of collusion designed to limit the ability of cancer victims to obtain justice.
A panel of judges has shut the door on an attempt by Bayer (OTCMKTS: BAYZF) and its Monsanto subsidiary to quietly settle a group of lawsuits under terms that threatened to restrict much larger multidistrict litigation (MDL) over the herbicide Roundup, potentially affecting thousands of cancer victims and even those not yet diagnosed.
LEVERKUSEN, Germany & EMERYVILLE, Calif., September 14, 2021--Leaps by Bayer, the impact investment arm of Bayer AG, today announced that it has co-led a USD 15 million Series A investment round in agriculture and biotechnology innovator, Andes, with Cavallo Ventures. Other new investors Builders VC, Germin8, Accelr8 and Wilson Sonsini participated, alongside existing investors KdT Ventures and Endurance.